These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 13718206)

  • 1. [Comparative studies on the efficacy of pentamidine, Solustibosan and Neostibosan against Candida albicans].
    IVADY G; FRIEDRICH E
    Dtsch Gesundheitsw; 1960 Oct; 15():2130-2. PubMed ID: 13718206
    [No Abstract]   [Full Text] [Related]  

  • 2. Activity of certain diamidines against blastomycosis and Candida infection in mice.
    SOLOTOROVSKY M; IRONSON EJ; GREGORY FJ; WINSTEN S
    Antibiot Chemother (Northfield); 1954 Feb; 4(2):165-8. PubMed ID: 24542893
    [No Abstract]   [Full Text] [Related]  

  • 3. [Recent observations in myeloma patients with special consideration of treatment with stilbamidine and pentamidine].
    HEILMEYER L
    Schweiz Med Wochenschr; 1949 Sep; 79(36):837. PubMed ID: 18148452
    [No Abstract]   [Full Text] [Related]  

  • 4. The pharmacology, mode of action and therapeutic potentialities of stilbamidine, pentamidine, propamidine and other aromatic diamidines a review.
    SCHOENBACH EB; GREENSPAN EM
    Medicine (Baltimore); 1948 Sep; 27(3):327-77. PubMed ID: 18885033
    [No Abstract]   [Full Text] [Related]  

  • 5. Stilbamidine in the treatment of histoplasmosis; two case reports.
    SEABURY JH
    Ann Intern Med; 1949 Sep; 31(3):520-3. PubMed ID: 18137170
    [No Abstract]   [Full Text] [Related]  

  • 6. Enhanced resistance against systemic Candida albicans infection in mice treated with C. albicans DNA.
    Dimitrova P; Yordanov M; Danova S; Ivanovska N
    FEMS Immunol Med Microbiol; 2008 Jul; 53(2):231-6. PubMed ID: 18507679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [New insight into the use of aromatic diamidines, especially of hexamidine, in the treatment of skin diseases].
    RIETH H
    Fortschr Med; 1962 Aug; 80():621-3. PubMed ID: 14492207
    [No Abstract]   [Full Text] [Related]  

  • 8. In vitro and in vivo effectiveness of egg yolk antibody against Candida albicans (anti-CA IgY).
    Ibrahim el-SM; Rahman AK; Isoda R; Umeda K; Van Sa N; Kodama Y
    Vaccine; 2008 Apr; 26(17):2073-80. PubMed ID: 18375022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The diamidines in chemotherapy; a survey of recent developments with a note regarding therapeutic trials in patients with rheumatoid arthritis.
    ROSENBERG EF
    Ann Intern Med; 1946 Nov; 25(5):832-44. PubMed ID: 20273933
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of local infection with diamidines.
    KOHN F; CROSS CD
    Lancet; 1948 Oct; 2(6530):647-51. PubMed ID: 18890508
    [No Abstract]   [Full Text] [Related]  

  • 11. Evaluation of the usefulness of anti-glyceraldehyde-3-phosphate dehydrogenase antibodies as a treatment for invasive candidiasis in a murine model.
    Gil ML; Dagan S; Eren R; Gozalbo D
    Antonie Van Leeuwenhoek; 2006; 89(3-4):345-50. PubMed ID: 16779630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of Candida albicans infections with a new fungicide antibiotic, nystatin].
    DROUGHET E
    Presse Med (1893); 1955 Apr; 63(30):620-3. PubMed ID: 14384762
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparative evaluation of four commercial tests for presumptive identification of Candida albicans.
    Cárdenes CD; Carrillo-Muñoz AJ; Arias A; Rodríguez-Alvarez C; Torres-Lana A; Sierra A; Arévalo MP
    J Microbiol Methods; 2004 Nov; 59(2):293-7. PubMed ID: 15369866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endogenous endophthalmitis with azole-resistant Candida albicans--Case report and review of the literature.
    Osthoff M; Hilge R; Schulze-Döbold C; Bogner JR
    Infection; 2006 Oct; 34(5):285-8. PubMed ID: 17033755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prevalence of Candida albicans and Candida non-albicans in clinical samples during 1999-2001].
    Mujica MT; Finquelievich JL; Jewtuchowicz V; Iovannitti CA
    Rev Argent Microbiol; 2004; 36(3):107-12. PubMed ID: 15559191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of high-dose granulocyte transfusions in patients with cancer with candidemia: retrospective case-control analysis of 491 episodes of Candida species bloodstream infections.
    Safdar A; Hanna HA; Boktour M; Kontoyiannis DP; Hachem R; Lichtiger B; Freireich EJ; Raad II
    Cancer; 2004 Dec; 101(12):2859-65. PubMed ID: 15529309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bilateral Candida albicans endophthalmitis associated with an infected deep venous thrombus.
    Arroyo JG; Bula DV; Grant CA; Murtha T
    Jpn J Ophthalmol; 2004; 48(1):30-3. PubMed ID: 14767647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Candida glabrata and Candida albicans; dissimilar tissue tropism and infectivity in a gnotobiotic model of mucosal candidiasis.
    Westwater C; Schofield DA; Nicholas PJ; Paulling EE; Balish E
    FEMS Immunol Med Microbiol; 2007 Oct; 51(1):134-9. PubMed ID: 17854475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prophylactic vaccination with phage-displayed epitope of C. albicans elicits protective immune responses against systemic candidiasis in C57BL/6 mice.
    Yang Q; Wang L; Lu DN; Gao RJ; Song JN; Hua PY; Yuan DW
    Vaccine; 2005 Jul; 23(31):4088-96. PubMed ID: 15963364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The importance of strain variation in virulence of Candida dubliniensis and Candida albicans: results of a blinded histopathological study of invasive candidiasis.
    Asmundsdóttir LR; Erlendsdóttir H; Agnarsson BA; Gottfredsson M
    Clin Microbiol Infect; 2009 Jun; 15(6):576-85. PubMed ID: 19604278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.